Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route.
AffiliationDepartment of Medical Microbiology, St Mary's Hospital Medical School, London, U.K.
MetadataShow full item record
AbstractA murine model based on infection by the respiratory route has been used to study the pathogenesis of recombinant vaccinia viruses. The neurovirulent Western Reserve (WR) strain and the Wyeth smallpox vaccine strain were used as vectors. Recombinant viruses were constructed by insertion of the Epstein-Barr virus membrane glycoprotein 340 gene into the thymidine kinase (TK) gene of each vaccinia virus. Intranasal inoculation of DBA/2 mice with 10(6) pock-forming units (pk.f.u.) of the WR strain was lethal but mice survived similar infection with the WR recombinant virus. Each virus was recovered from lung, blood and brain but, unlike wild-type virus, the recombinant virus was subsequently cleared. No deaths occurred after similar infection with the Wyeth strain or the Wyeth recombinant virus. There was limited growth of the Wyeth strain in the respiratory tract, low levels of virus in the blood and only sporadic recovery in brain extracts. The Wyeth recombinant virus was cleared rapidly with little viraemia or detectable infection of the central nervous system. No phenotypic character determined in vitro could be related consistently to the virulence of wild-type and recombinant viruses. Although the lethal character of the WR strain was affected by its TK+ phenotype, mice survived infection by intranasal inoculation with 10(6) pk.f.u. of WR TK+ recombinant viruses which either expressed the human interleukin 2 gene or had a deficient vaccinia virus growth factor gene.
CitationBiological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. 1990, 71 ( Pt 11):2761-7 J. Gen. Virol.
JournalJournal of General Virology
- Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses.
- Authors: Hayasaka D, Ennis FA, Terajima M
- Issue date: 2007 Feb 27
- Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice.
- Authors: Taylor G, Stott EJ, Wertz G, Ball A
- Issue date: 1991 Jan
- Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
- Authors: McCart JA, Ward JM, Lee J, Hu Y, Alexander HR, Libutti SK, Moss B, Bartlett DL
- Issue date: 2001 Dec 15
- Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.
- Authors: Buller RM, Smith GL, Cremer K, Notkins AL, Moss B
- Issue date: 1985 Oct 31-Nov 6
- Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.
- Authors: Ramírez JC, Gherardi MM, Esteban M
- Issue date: 2000 Jan